Your browser doesn't support javascript.
loading
Predictors of Survival in Friedreich's Ataxia: A Prospective Cohort Study.
Indelicato, Elisabetta; Reetz, Kathrin; Maier, Sarah; Nachbauer, Wolfgang; Amprosi, Matthias; Giunti, Paola; Mariotti, Caterina; Durr, Alexandra; de Rivera Garrido, Francisco J R; Klopstock, Thomas; Schöls, Ludger; Klockgether, Thomas; Bürk, Katrin; Pandolfo, Massimo; Didszun, Claire; Grobe-Einsler, Marcus; Nanetti, Lorenzo; Nenning, Lukas; Kiechl, Stefan; Dichtl, Wolfgang; Ulmer, Hanno; Schulz, Jörg B; Boesch, Sylvia.
Afiliação
  • Indelicato E; Center for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Reetz K; Department of Neurology, RWTH Aachen University, Aachen, Germany.
  • Maier S; JARA-BRAIN Institute of Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH and RWTH Aachen University, Aachen, Germany.
  • Nachbauer W; Institute of Medical Statistics and Informatics, Medical University Innsbruck, Innsbruck, Austria.
  • Amprosi M; Center for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Giunti P; Center for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Mariotti C; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
  • Durr A; Unit of Genetics of Neurodegenerative and Metabolic Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • de Rivera Garrido FJR; Institut du Cerveau et de la Moelle Epinière, INSERM U1127, CNRS UMR 7225, Sorbonne Universités, UPMC Université Paris VI UMR S1127, Paris, France.
  • Klopstock T; APHP, Genetics Department, Pitié-Salpêtrière University Hospital, Paris, France.
  • Schöls L; Reference Unit of Hereditary Ataxias and Paraplegias, Department of Neurology, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
  • Klockgether T; Department of Neurology with Friedrich-Baur-Institute, University of Munich, Munich, Germany.
  • Bürk K; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
  • Pandolfo M; Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
  • Didszun C; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
  • Grobe-Einsler M; Department of Neurology, University Hospital of Bonn, Bonn, Germany.
  • Nanetti L; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Nenning L; Department of Neurology, Philipps University of Marburg, Marburg, Germany.
  • Kiechl S; Laboratory of Experimental Neurology, Université Libre de Bruxelles, Brussels, Belgium.
  • Dichtl W; Department of Neurology and Neurosurgery, McGill University, Montreal, Canada.
  • Ulmer H; Department of Neurology, RWTH Aachen University, Aachen, Germany.
  • Schulz JB; JARA-BRAIN Institute of Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH and RWTH Aachen University, Aachen, Germany.
  • Boesch S; Department of Neurology, University Hospital of Bonn, Bonn, Germany.
Mov Disord ; 39(3): 510-518, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38140802
ABSTRACT

BACKGROUND:

Friedreich's ataxia (FA) is a rare multisystemic disorder which can cause premature death.

OBJECTIVES:

To investigate predictors of survival in FA.

METHODS:

Within a prospective registry established by the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS; ClinicalTrials.gov identifier NCT02069509) we enrolled genetically confirmed FA patients at 11 tertiary centers and followed them in yearly intervals. We investigated overall survival applying the Kaplan-Meier method, life tables, and log-rank test. We explored prognostic factors applying Cox proportional hazards regression and subsequently built a risk score which was assessed for discrimination and calibration performance.

RESULTS:

Between September 2010 and March 2017, we enrolled 631 FA patients. Median age at inclusion was 31 (range, 6-76) years. Until December 2022, 44 patients died and 119 terminated the study for other reasons. The 10-year cumulative survival rate was 87%. In a multivariable analysis, the disability stage (hazard ratio [HR] 1.51, 95% CI 1.08-2.12, P = 0.02), history of arrhythmic disorder (HR 2.93, 95% CI 1.34-6.39, P = 0.007), and diabetes mellitus (HR 2.31, 95% CI 1.05-5.10, P = 0.04) were independent predictors of survival. GAA repeat lengths did not improve the survival model. A risk score built on the previously described factors plus the presence of left ventricular systolic dysfunction at echocardiography enabled identification of four trajectories to prognosticate up to 10-year survival (log-rank test P < 0.001).

CONCLUSIONS:

Arrhythmias, progressive neurological disability, and diabetes mellitus influence the overall survival in FA. We built a survival prognostic score which identifies patients meriting closer surveillance and who may benefit from early invasive cardiac monitoring and therapy. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ataxia de Friedreich / Diabetes Mellitus Limite: Adolescent / Adult / Aged / Child / Humans / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ataxia de Friedreich / Diabetes Mellitus Limite: Adolescent / Adult / Aged / Child / Humans / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article